Category

Daily Briefs

Daily Brief Industrials: SK Square , Xylem Inc, Veralto , Ningbo Joyson Electronic, Hesai Group, Impro Precision Industries, Grab Holdings , Toa Corp, Yamada Consulting Group Co L, Car Inc and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Reading the Latest Flow Patterns to Time a SK Square NAV Squeeze Trade
  • Xylem Teams Up with Amazon: How Smart Water Tech Is Reshaping Global Cities!
  • Veralto’s Data Center Revolution – How Water Tech Became the Next Big Thing in AI!
  • Ningbo Joyson IPO Trading: Tight Premium and Mediocre Insti Demand
  • Primer: Hesai Group (2525 HK) – Nov 2025
  • Primer: Impro Precision Industries (1286 HK) – Nov 2025
  • Grab Holdings: Growth Engines Continue to Rev – What’s Powering the Momentum?
  • Toa Corp (1885 JP): Coverage Initiation
  • Yamada Consulting Group Co L (4792 JP): 1H FY03/26 flash update
  • Primer: Car Inc (699 HK) – Nov 2025


Reading the Latest Flow Patterns to Time a SK Square NAV Squeeze Trade

By Sanghyun Park

  • Retail flow drove the ratio: selling pushed it higher, buying dragged it lower. Pre‑Sept they dip‑bought and flipped; since late Sept they’ve chased longs, fueling Hynix’s rally.
  • Instos joined retail chasing Hynix, juicing momentum; KRX’s investment‑alert acts as a speed bump, likely cooling hot‑money flows and tilting the ratio in Square’s favor.
  • But retail still drives Hynix; until they cool off, Square NAV squeeze is early. A sector‑wide AI pivot cooling retail frenzy is the real catalyst, bigger than KRX’s alert.

Xylem Teams Up with Amazon: How Smart Water Tech Is Reshaping Global Cities!

By Baptista Research

  • Xylem Inc., a leading global water technology company, reported solid results in the third quarter of 2025.
  • The company demonstrated strong financial performance with notable growth across its segments and has adjusted its full-year outlook upwards due to ongoing robust demand and efficient execution of its strategic initiatives.
  • Positively, Xylem registered an increase in revenue across all its segments, with a marked double-digit growth in both Measurement and Control Solutions (MCS) and Water Solutions and Services (WSS).

Veralto’s Data Center Revolution – How Water Tech Became the Next Big Thing in AI!

By Baptista Research

  • Veralto Corporation delivered a robust yet nuanced performance in the third quarter of 2025, reflecting significant progress across its key business segments amidst a continually evolving macroeconomic landscape.
  • The company reported a 5.1% increase in core sales and an 11% growth in adjusted earnings per share, propelled by strong execution within its Water Quality and Product Quality & Integrity (PQI) sectors.
  • Despite navigating challenges such as global trade policy shifts, Veralto raised its full-year adjusted earnings per share guidance, showcasing resilience and adaptability.

Ningbo Joyson IPO Trading: Tight Premium and Mediocre Insti Demand

By Nicholas Tan

  • Ningbo Joyson Electronic (600699 CH) is looking to raise up to US$471m in its upcoming Hong Kong IPO.
  • NBJ, is an intelligent automotive technology solution provider, offering advanced products and solutions across the auto part industry’s key areas including automotive electronics and automotive safety.
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

Primer: Hesai Group (2525 HK) – Nov 2025

By αSK

  • Global LiDAR Market Leader Poised for Growth: Hesai Group is a global leader in the LiDAR (Light Detection and Ranging) solutions market, holding the top position in terms of revenue for three consecutive years. The company has a dominant market share in both the automotive and robotaxi segments, with a 37% global market share by revenue in 2023. Positioned to capitalize on the rapidly expanding LiDAR market, which is projected to grow at a CAGR of over 12-20% annually, Hesai is well-situated to benefit from the increasing adoption of Advanced Driver Assistance Systems (ADAS) and autonomous vehicles.
  • Strong Revenue Growth and Path to Profitability: The company has demonstrated impressive top-line growth, with revenues increasing significantly year-over-year. Recent quarterly results show a marked improvement in financial performance, with a substantial narrowing of net losses and the achievement of non-GAAP profitability ahead of schedule. This is driven by a massive increase in LiDAR shipments, particularly for ADAS applications, reflecting strong market demand and successful scaling of its in-house manufacturing capabilities.
  • Geopolitical Risks and Competitive Pressures Remain Key Overhangs: Despite its market leadership and growth trajectory, Hesai faces significant risks. The company was added to the U.S. Department of Defense’s list of “Chinese Military Companies,”which it vehemently disputes as baseless and commercially motivated. This designation, coupled with intense competition in the LiDAR space leading to pricing pressure, creates uncertainty and could impact its global expansion plans and margin stability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Impro Precision Industries (1286 HK) – Nov 2025

By αSK

  • Diversified End-Market Exposure Mitigates Cyclicality: Impro serves a wide range of industries, including automotive, high-horsepower engines, aerospace, medical, and construction. This diversification helps to cushion the impact of downturns in any single sector. Recent strength in the aerospace and high-horsepower engine (driven by AI data center demand) segments has offset weakness in others.
  • Strong Financial Performance and Shareholder Returns: The company has demonstrated a solid growth track record, particularly over the last three years, with an 18.95% CAGR in net income and a 40.46% CAGR in free cash flow. This financial strength supports a consistent and attractive dividend yield, which stood at 8.2% in the most recent fiscal year.
  • Strategic Global Footprint and ‘One-Stop Shop’ Capabilities: With manufacturing facilities in China, Mexico, Turkey, and Europe, Impro is well-positioned to serve its global customer base and mitigate geopolitical risks. Its comprehensive service offering, from design and casting to precision machining and surface treatment, provides a key competitive advantage and deepens customer relationships.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Grab Holdings: Growth Engines Continue to Rev – What’s Powering the Momentum?

By Devi Subhakesan

  • Grab Holdings (GRAB US)  delivered solid Q3 2025 results with healthy revenue and margin expansion across segments, but lagged consensus forecasts.
  • Growth in Q32025 was driven by rising MTU, strong Mart and Advertising momentum among other factors.
  • Management believes that the growth seen in recent quarters are sustainable, without sacrificing profitability. Raised full year guidance marginally.

Toa Corp (1885 JP): Coverage Initiation

By Shared Research

  • In FY03/25, the company reported record-high results, with revenue of JPY330.5bn (+16.4% YoY), operating profit of JPY20.6bn (+19.7% YoY), recurring profit of JPY20.1bn (+20.7% YoY), and net income attributable to owners of the parent of JPY14.9bn (+41.8% YoY).
  • Orders (parent) totaled JPY353.8bn (+0.3% YoY), also a record high. Revenue exceeded the initial forecast by 10.2%, reflecting steady progress on large projects in the Domestic Civil Engineering, Domestic Building Construction, and Overseas businesses.
  • Orders (parent) surpassed the initial forecast by 68.5%, boosted by early booking of overseas projects originally scheduled for FY03/26.

Yamada Consulting Group Co L (4792 JP): 1H FY03/26 flash update

By Shared Research

  • Revenue increased by 7.6% YoY to JPY13.4bn, while operating profit decreased by 27.9% YoY to JPY2.1bn.
  • Consulting business revenue was JPY9.6bn, with a 41.3% YoY decline in operating profit, driven by higher SG&A expenses.
  • Investment business revenue rose 64.2% YoY to JPY3.7bn, with operating profit exceeding the full-year target at 113.2%.

Primer: Car Inc (699 HK) – Nov 2025

By αSK

  • Privatization and Delisting: Car Inc. was privatized by private equity firm MBK Partners and delisted from the Hong Kong Stock Exchange on July 8, 2021, following a period of significant financial distress and corporate governance concerns. This report analyzes the company’s performance and position leading up to this event.
  • Market Leadership Under Pressure: Historically one of China’s largest car rental companies, Car Inc.’s market position was eroded by intense competition, the negative impact of the COVID-19 pandemic, and its association with the Luckin Coffee accounting scandal through its founder, Charles Lu Zhengyao.
  • Challenging Financial Trajectory: The company exhibited a significant deterioration in financial performance, with declining revenue, negative margins, and substantial net losses in the period leading up to its privatization. This was a stark reversal from its previously profitable operations.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Utilities: Adani Energy Solutions and more

By | Daily Briefs, Utilities Sector

In today’s briefing:

  • Lucror Analytics – Morning Views Asia


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Adani Energy Solutions, Adani Ports, Bharti Airtel
  • UST yields declined c. 3 bps across the curve yesterday as treasuries advanced amid a slump in risk assets, with the yield on the 2Y and 10Y UST falling to 3.58% and 4.09%, respectively.
  • Equities retreated, after several Wall Street chief executives expressed caution about stretched valuations.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Sumitomo Chemical, Bluescope Steel, Expand Energy, Ocean Power Technologies, Crude Oil, D3 Energy, GCC SAB de CV, Major Drilling Group Intl, Cardinal Resources, BP PLC and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • StubWorld: Sumitomo Chemical/Sumitomo Pharma, Hyundai Motor/ Kia Corp, Ecopro Co/Ecopro BM
  • Long Bluescope (BSL AU) Vs. Short Sims (SGM AU): Statistical Arbitrage in Aussie Steel
  • Expand Energy Eyes Western Haynesville Boom – Could This Be Its Next Big Jackpot?
  • OPTT: Backlog Booming with Strategic Transformation to Commercial Operations
  • Oil futures: Crude trades in tight range, Brent eases below $64/b
  • D3 Energy Limited – Ahead of budget, ahead of the curve
  • GCC SAB de CV – Actinver Research
  • Primer: Major Drilling Group Intl (MDI CN) – Nov 2025
  • Primer: Cardinal Resources (CDV AU) – Nov 2025
  • bp — Solid Q325 results, portfolio progress


StubWorld: Sumitomo Chemical/Sumitomo Pharma, Hyundai Motor/ Kia Corp, Ecopro Co/Ecopro BM

By David Blennerhassett

  • For a change of pace, this insight briefly canvasses a clutch of Holdco’s trading at extreme levels, in both “set-up” and “unwind” territory.
  • Preceding the chart/table-heavy insight are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

Long Bluescope (BSL AU) Vs. Short Sims (SGM AU): Statistical Arbitrage in Aussie Steel

By Gaudenz Schneider

  • Context: The Bluescope Steel (BSL AU) vs. Sims Metal (SGM AU) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Going long Bluescope (BSL AU) and short Sims (SGM AU) targets a 6% return.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Expand Energy Eyes Western Haynesville Boom – Could This Be Its Next Big Jackpot?

By Baptista Research

  • Expand Energy’s latest quarterly results highlight both positive strides and challenges within the company’s operations and strategic outlook.
  • The company has pursued capital efficiency, managing to reduce costs significantly while increasing production, particularly in the Haynesville region.
  • Expand Energy has demonstrated an impressive cost reduction in well expenses by over 25% and outperformed peers with year-to-date costs 30% lower, thanks to optimized development and completion designs.

OPTT: Backlog Booming with Strategic Transformation to Commercial Operations

By Water Tower Research

  • Ocean Power Technologies, Inc. (NYSE American: OPTT) delivers an extensive range of ocean-intelligence solutions using advanced autonomous systems and specialized software. 
  • The company has transformed from a wave energy developer into an integrated provider of ocean intelligence solutions, combining PowerBuoy® persistent power stations, Wave Adaptive Modular Vessel (WAM-V®) unmanned surface vehicles (USVs), and the AI-capable Merrows™ command and control system.
  • This integrated approach addresses critical gaps in maritime domain awareness for defense, offshore energy, and ocean research markets in the US as well as overseas.

Oil futures: Crude trades in tight range, Brent eases below $64/b

By Quantum Commodity Intelligence

  • Crude oil futures were lower Wednesday but benchmarks continued to trade in the narrow range in place since last week.
  • Front-month Jan25 ICE Brent futures were trading at $63.54/b (2135 BST) versus Tuesday’s settle of $64.44/b, while Dec25 NYMEX WTI was at $59.62/b against a previous close of $60.66/b.
  • The market has been looking for direction since Sunday’s OPEC+ meeting when the eight members taking part in voluntary cuts added another 137,0000 bpd to quotas in December, although countered this with a pause on any further increases in Q1.

D3 Energy Limited – Ahead of budget, ahead of the curve

By Research as a Service (RaaS)

  • D3 Energy Limited (ASX:D3E) continues to represent a compelling investment case as a leveraged play on natural gas and helium projects in South Africa.
  • The association of natural gas with globally significant helium concentrations gives the company a material point of differentiation compared to its listed upstream peers.
  • D3E has delivered significantly positive results through its first stage drilling and testing activity, independent certification of initial reserves and resources, and a Production Right Area (PRA) application that could see the company at a project sanction stage by end-2026.


Primer: Major Drilling Group Intl (MDI CN) – Nov 2025

By αSK

  • Major Drilling is a global leader in specialized contract drilling for the mining industry, strategically positioned to benefit from increased exploration budgets, particularly for metals essential to the energy transition.
  • The company’s extensive experience, modern fleet, and focus on specialized, complex drilling projects create a competitive advantage and support relationships with major mining companies.
  • Financial performance is inherently tied to the cyclical nature of the mining industry and commodity prices, with recent results showing margin pressure despite long-term revenue growth.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Cardinal Resources (CDV AU) – Nov 2025

By αSK

  • Cardinal Resources was a single-asset gold development company whose primary value was derived from its 100%-owned Namdini Gold Project in Ghana, a large-scale, long-life asset.
  • In 2020, the company became the subject of a prolonged and competitive bidding war, primarily between Russia’s Nordgold and China’s Shandong Gold, which significantly drove up its valuation and highlighted the strategic appeal of the Namdini project.
  • The company was ultimately acquired by Shandong Gold Mining (HongKong) Co., Limited in a transaction that concluded in early 2021, leading to the delisting of Cardinal Resources from the ASX and TSX in February 2021.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


bp — Solid Q325 results, portfolio progress

By Edison Investment Research

bp reported Q325 underlying replacement cost (RC) profit of $2.2bn (Q225: $2.4bn), with stronger operating performance partly offset by a higher tax rate (due to regional profit mix changes). Operating cash flow rose to $7.8bn from $6.3bn, supported by a working capital release of around $0.9bn compared to a $1.4bn build last quarter. Net debt remained stable at $26.1bn, despite redeeming $1.2bn in hybrid bonds. The dividend was maintained at 8.32c per share, and bp announced a further $0.75bn share buyback to be completed before the Q4 results. Capital expenditure of $3.4bn was consistent with FY25 guidance of around $14.5bn.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Pony AI, Microsoft Corp, Groww, All Winner Technology, Info-Tech Systems, Zebra Technologies Corp, Advanced Micro Devices, Teradyne Inc, Milian Technology and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Pony.AI Hong Kong Public Offering Valuation Analysis
  • PonyAI and WeRide Secondary HK Trading – Weakish Demand, WeRide Did Better but Trading Lower
  • Microsoft’s OpenAI Conundrum
  • Groww IPO Review – India’s Largest & Fastest Growing Broker / Investment Platform.
  • CES China Semiconductor Chips Index Rebalance Preview: One Change Likely in Dec
  • Info -Tech Systems Limited Initiating Coverage
  • Zebra Technologies: How Its RFID Empire Is Taking Over Multiple Industries!
  • AMD: Management Expects Revenue Re-Acceleration from 2H26 with MI400 Launch
  • Teradyne Inc.: Strategic Positioning in the Memory Market to Enhance Market Share & Revenue In Memory Testing Segment!
  • Milian Technology IPO Valuation Analysis: A Dating App Company May Seek Unicorn Valuation In HK IPO


Pony.AI Hong Kong Public Offering Valuation Analysis

By Douglas Kim

  • Pony.ai has finalized the Hong Kong public offering price at HK$139 per share and it expects to raise HK$6.71 billion (US$860 million) from its planned secondary listing in Hong Kong. 
  • Our base case valuation of Pony.Ai is HK$178.2 per share over the next 6-12 months, which represents 28% higher than the Hong Kong public offering price. 
  • Given the solid upside, we have a Positive View of Pony.ai. Despite our Positive view, there have been increasing concerns about the overstretched valuations of major AI/tech related companies globally.

PonyAI and WeRide Secondary HK Trading – Weakish Demand, WeRide Did Better but Trading Lower

By Sumeet Singh

  • Pony AI (PONY US) raised around US$860m and WeRide (WRD US) raised around US$310m in their HK Secondary offering.
  • We have looked at the deal dynamics in our previous note.
  • In this note, we talk about the trading dynamics for the two deals.

Microsoft’s OpenAI Conundrum

By William Keating

  • In Q126, Microsoft recorded $4.1 billion in net losses from investments in OpenAI, up from $688 million in the year ago quarter.
  • The newly updated partnership between Microsoft and OpenAI has many clauses contingent on when (not if) AGI gets declared. Since AGI has no actual definition, an expert panel will decide. 
  • Sam Altman dreams of an OpenAI IPO so that detractors can be lured into shorting the stock and getting burned in the process. Revenue growth is a touchy subject, apparently

Groww IPO Review – India’s Largest & Fastest Growing Broker / Investment Platform.

By Himanshu Dugar

  • Groww is India’s largest stockbroker with 13mn active users. It is progressing towards a full-stack investment platform, expecting to cross-sell multiple financial products to over 18mn users on its platform.
  • It is aggressively expanding into lending (MTF, LAS) and has recently acquired ‘Fisdom’ to offer premiumised wealth solutions (AIF, insurance, tax-filing). It also owns Groww AMC, offering debt/equity/Fixed income products.
  • At 33 times FY25 earnings, IPO is priced reasonably considering its deep penetration in the market (customers from 98% Pincodes) and strong ARPU and profitability supported by decent retention metrics.

CES China Semiconductor Chips Index Rebalance Preview: One Change Likely in Dec

By Brian Freitas


Info -Tech Systems Limited Initiating Coverage

By Impact Capital Asset Management

  • Info -Tech is led by Mr. Ricky Lim, Founder and Chairman, who started the company in 2007 with Mr. Babu Dilip, Co -founder and Chief Executive Officer.
  • The business remains founder -led, with senior management comprising long -serving functional heads across product, technology, and sales.
  • Ownership is concentrated among the founder and key management, aligning incentives with long – term growth and profitability.

Zebra Technologies: How Its RFID Empire Is Taking Over Multiple Industries!

By Baptista Research

  • Zebra Technologies reported its third-quarter 2025 results, surpassing its initial outlook.
  • The company posted $1.3 billion in sales, representing a year-on-year increase of 5%.
  • Adjusted EBITDA margin improved slightly by 20 basis points to 21.6%, and non-GAAP diluted EPS rose by 11% to $3.88.

AMD: Management Expects Revenue Re-Acceleration from 2H26 with MI400 Launch

By Nicolas Baratte

  • Good 3Q25, good 4Q guidance, optimism that the Server CPU market is growing faster, new GPU MI400 (2H26) will re-accelerate growth. Plus some price increase or higher ASP. Not controversial.
  • More controversial is Consensus expecting OP margin to jump from 24% (2025) to 31% (2027). There will be leverage as Data Center AI revenues grow – but it looks optimistic.
  • Valuations are elevated (41x 2026 EPS) for good reasons 1) Server share gains 2) rapid AI growth 3) higher ASP. After a vertical rally, the share price needs some room.

Teradyne Inc.: Strategic Positioning in the Memory Market to Enhance Market Share & Revenue In Memory Testing Segment!

By Baptista Research

  • Teradyne Inc. reported robust financial results for the third quarter of 2025, with a notable revenue growth of 18% and a significant increase in non-GAAP EPS by 49%.
  • This performance was primarily driven by heightened demand for semiconductor tests related to AI applications.
  • The UltraFLEXplus platform, which is tailored for high-performance processors and networking devices, has seen increased use due to the complexities of AI devices, indicating the strategic advantage of Teradyne’s focused R&D investments.

Milian Technology IPO Valuation Analysis: A Dating App Company May Seek Unicorn Valuation In HK IPO

By Andrei Zakharov

  • Milian Technology files for Hong Kong IPO and seeks fresh capital for further expanding its global presence and accelerating overseas market penetration.  
  • Xiaomi backed online social networking platform company is one of the fastest growing marriage and dating platforms in China, reaching RMB2,373m revenue in 2024, up ~129% YoY.
  • I expect Milian Technology may seek unicorn valuation in upcoming HK IPO as growth is exceptionally high and profitability improved.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: China Medical System, Neurocrine Biosciences, ResMed Inc, Tenet Healthcare, D.Western Therapeutics Institute Inc., Otsuka Holdings, Biohaven , Vertex Pharmaceuticals, Edesa Biotech , Incyte Corp and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • China Medical Systems Holdings Limited Initiating Coverage
  • Neurocrine Biosciences Doubles Down on CRENESSITY – Can This Strategy Dominate the CAH Market?
  • Tariff Uncertainty Negates ResMed’s Q1 Positives
  • Tenet Healthcare’s Multi-Billion Bet on Tech & M&A – Will It Pay Off?
  • News Flash: D. Western Therapeutics Institute (4576 JP) – November 5, 2025
  • Otsuka Holdings (4578 JP): Rexulti, Abilify Drive 2025 Guidance Upward, All Eyes on Sibeprenlimab
  • Primer: Biohaven ( BHVN US) – Nov 2025
  • Vertex Pharma’s Painkiller Collapse Sends Shockwaves—But One Drug Could Save It All!
  • EDSA: EB05 Reduces Risk of Death 25% in Phase 3 ARDS Trial
  • Incyte Unveils Game-Changing mCALR Trials – What It Means for Blood Cancer Treatment!


China Medical Systems Holdings Limited Initiating Coverage

By Impact Capital Asset Management

  • The company’s founder Mr. Lam Kong serves as Chairman, Chief Executive and President.
  • The other key management personnel are Ms. Chen Yanling who is the Executive Director and CFO.
  • The company’s six -member board comprises two executives, one non -executive, and three independent non -executive directors. Committees cover Audit, Remuneration, Nomination, and ESG, with INEDs forming the majority on committees.

Neurocrine Biosciences Doubles Down on CRENESSITY – Can This Strategy Dominate the CAH Market?

By Baptista Research

  • In the third quarter of 2025, Neurocrine Biosciences reported robust financial and operational performance.
  • The period was marked by $790 million in net product sales, a 28% year-over-year increase, driven by their flagship drugs INGREZZA and CRENESSITY.
  • INGREZZA, used for treating tardive dyskinesia and Huntington’s chorea, saw continued growth attributed to recent expansions of the sales force and improved patient access, resulting in record new patient starts and prescriptions.

Tariff Uncertainty Negates ResMed’s Q1 Positives

By FNArena

  • ResMed’s first-quarter result broadly met market expectations, though rising margins and potential for further capital management have been negated by US import tariff ambiguity.
  • ResMed updates with strong September quarter performance (but largely in line) Gross margin surprised, device revenues outperform expectation Uncertainty about US import tariff exemption weighs on share price Expects share buybacks of US$150m in each quarter of FY26 Ord Minnett sees scope for additional capital management initiatives

Tenet Healthcare’s Multi-Billion Bet on Tech & M&A – Will It Pay Off?

By Baptista Research

  • Tenet Healthcare reported a robust financial performance for the third quarter of 2025, exceeding expectations with significant growth in revenue and EBITDA.
  • The company’s net operating revenue reached $5.3 billion, demonstrating strong operational efficiency and growth.
  • Consolidated adjusted EBITDA was reported at $1.1 billion, which marked a 12% year-over-year increase and reflected an improved EBITDA margin of 20.8%.

News Flash: D. Western Therapeutics Institute (4576 JP) – November 5, 2025

By Sessa Investment Research

  • DWTI announced after the close on 11/4 that 84.6% of the Series 13 Share Acquisition Rights (with exercise price adjustment clause) issued on July 31, 2025, have already been exercised in just three months since the issue (see table below). In other words, this leaves only 1.5mn shares, or 3.37% dilution remaining.
  • This marks a significant decline in selling pressure going forward, ahead of multiple expected share price catalysts, including 1) China launch of DW-1002 (Brilliant Blue G) for indication ILM staining as an aid for ophthalmic surgeries
  • 2) expected H1 2026 US launch of DW-5LBT (lidocaine patch, trade name Bondlido), as a treatment for neuropathic pain after shingles (post-herpetic neuralgia) in adults, and 3) announcement of details of the Japan development plan for new pipeline candidate H-1129 as a treatment for corneal and conjunctival diseases caused by immune disorders.

Otsuka Holdings (4578 JP): Rexulti, Abilify Drive 2025 Guidance Upward, All Eyes on Sibeprenlimab

By Tina Banerjee

  • Otsuka Holdings (4578 JP) witnessed 5% revenue growth in 9M25, despite negative Fx impact. Mainstay pharmaceutical business (+6.5% YoY) drove revenue. Rexulti and Abilify remained strong.
  • Otsuka has revised 2025 guidance upwards on the back of steady progress in Pharma and Nutraceutical business. Overall, 2025 revenue is now expected to be ¥2420B (previous guidance ~ ¥2380B).
  • Otsuka’s two top selling drugs are steadily gaining traction, mainly in the U.S. Going ahead, the company is banking on new drugs like sibeprenlimab to further drive growth.

Primer: Biohaven ( BHVN US) – Nov 2025

By αSK

  • Biohaven is a clinical-stage biopharmaceutical company that emerged from the acquisition of its migraine franchise by Pfizer, now focusing on a diversified pipeline in neuroscience, immunology, and oncology.
  • The company’s future hinges on the clinical and regulatory success of its late-stage assets, particularly troriluzole for neurological disorders and BHV-7000 for epilepsy, alongside a broad early-stage pipeline leveraging novel platforms like extracellular protein degradation.
  • Financially, Biohaven is in a pre-revenue stage, characterized by significant R&D investment and net losses. Its success is dependent on managing cash burn and securing future funding or partnerships to advance its extensive pipeline to commercialization.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Vertex Pharma’s Painkiller Collapse Sends Shockwaves—But One Drug Could Save It All!

By Baptista Research

  • Vertex Pharmaceuticals has entered a critical inflection point following the high-profile failure of its experimental non-opioid painkiller, VX-993, in a Phase 2 trial.
  • Since August 2025, the company has shed over 11% of its market value, as hopes dimmed for the oral variant of its FDA-approved nonaddictive analgesic Journavax.
  • Yet, the Q3 2025 earnings report offered a reprieve.

EDSA: EB05 Reduces Risk of Death 25% in Phase 3 ARDS Trial

By Zacks Small Cap Research

  • On October 28, 2025, Edesa Biotech, Inc. (EDSA) announced positive results from a Phase 3 clinical trial evaluating paridiprubart (EB05) as a treatment for Acute Respiratory Distress Syndrome (ARDS).
  • EB05 met both the primary and secondary endpoints of the study, which included a statistically significant and clinically meaningful 25% relative risk reduction in the risk of death compared to placebo (P<0.001).
  • Across the 275 patients that were enrolled for the Phase 2 and Phase 3 studies, EB05 was generally well-tolerated and consistent with the observed safety profile to date.

Incyte Unveils Game-Changing mCALR Trials – What It Means for Blood Cancer Treatment!

By Baptista Research

  • Incyte Corporation’s third quarter 2025 earnings results reveal a mix of growth and challenges for the company.
  • The company’s total revenues reached $1.37 billion, representing a year-over-year increase of 20%, with product sales contributing $1.15 billion.
  • The growth was driven mainly by key products like Jakafi and Opzelura, as well as promising performances from new launches such as Niktimvo.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Toyota Industries, Mandom Corp, Physicswallah Limited, The Pinkfong Company, BYD, Cisarua Mountain Dairy, Wayfair Inc Class A, Black Rock Coffee Bar, Ferrari N.V. and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Toyota Industries (6201 JP): Market Movements Support the Case of a Higher Offer
  • [Japan Activism] Mandom (4917 JP) – Murakami at 20% and Mandom Offers A Sweet Poison Pill
  • Physicswallah IPO: Index Inclusion Possibilities & Timing
  • The Pinkfong Company IPO Book Building Analysis
  • BYD (1211 HK) Tactical Outlook: Still Downtrending, But OVERSOLD
  • Physicswallah Pre-IPO – The Positives – Has Had a Dream Run
  • Primer: Cisarua Mountain Dairy (CMRY IJ) – Nov 2025
  • Wayfair: What You Didn’t Know About Its Multichannel Fulfillment Takeover!- Major Drivers
  • Black Rock Coffee Bar (BRCB US): Limited but Direct US & Global Index Inclusion
  • Ferrari (RACE US) Q3 FY25: Beat + Revision Of Guidance Upwards


Toyota Industries (6201 JP): Market Movements Support the Case of a Higher Offer

By Arun George

  • Last month, nearly two dozen global asset managers, through ACGA, submitted a joint letter to the boards of Toyota Industries (6201 JP) and Toyota Motor regarding the tender offer.
  • The letter outlined five issues, which distilled down to concerns about a low-balled offer. Their cause is increasingly supported by market movements, which support the case for the bump.
  • Recent activism against several low-balled tenders signals that TICO, despite its size, is not immune. My SoTP valuation is JPY19,607, which is 20.3% above the offer price.

[Japan Activism] Mandom (4917 JP) – Murakami at 20% and Mandom Offers A Sweet Poison Pill

By Travis Lundy

  • Mandom Corp (4917 JP) yesterday decided to launch a question-response effort for the Murakami-san Group ownership of Mandom shares up to and above 20%. This is a Poison Pill precursor.
  • There’s a drawn out set of questions, answers, etc, at the end of which, the Independent Committee will decide that Murakami is a Bad Person and the Poison Pill proceeds.
  • Murakami Group is apparently now over 20%. That’s a little tricky. But this looks like a Good Poison Pill. 

Physicswallah IPO: Index Inclusion Possibilities & Timing

By Brian Freitas

  • Physicswallah Limited (2076103D IN) is looking to list on the exchanges by selling 319.26m shares via a primary and secondary offering to raise US$392m at a valuation of US$3.5bn.
  • The price band has been set at INR 103-109/share, and the issue is likely to price at the top end of the range.
  • The stock will be added to the AMFI Smallcap segment and inclusion in the Nifty Smallcap 250 index is likely in March. Global index inclusion could commence in June.

The Pinkfong Company IPO Book Building Analysis

By Douglas Kim

  • The Pinkfong Company successfully completed its IPO book building process. It finalized the IPO price at 38,000 won (high end of the IPO price range). 
  • A total of 2,300 domestic and international institutions participated in the book building process. The IPO competition ratio was 615.9 to 1.  
  • Our base case valuation of the Pinkfong Co is implied market cap of 671.4 billion won or target price of 46,369 won per share (over the next 6-12 months). 

BYD (1211 HK) Tactical Outlook: Still Downtrending, But OVERSOLD

By Nico Rosti

  • BYD (1211 HK) does not seem ready yet to reverse its downtrend, sentiment is still negative (not too negative), Q3 revenues decreased (no surprise, as recently noted by Ming Lu).
  • BYD is short-term OVERSOLD, this is a tactical WEEKLY view presenting an actionable opportunity with a 1-3 week trade horizon (probably a 2 weeks rebound, maximum).
  • Our quantitative models say the stock will not correct for more than 3 weeks when this pattern is encountered (the stock is currently in its second consecutive week down).

Physicswallah Pre-IPO – The Positives – Has Had a Dream Run

By Sumeet Singh

  • Physicswallah is looking to raise about US$434m in its upcoming India IPO.
  • Physicswallah Ltd (PWL) offers test preparation courses for competitive examinations, and other courses such as for upskilling, across 13 education categories, including JEE, NEET, and UPSC, among others.
  • In this note, we talk about the positive aspects of the deal.

Primer: Cisarua Mountain Dairy (CMRY IJ) – Nov 2025

By αSK

  • Dominant Player in a High-Growth Market: Cisarua Mountain Dairy (CMRY) is a leading producer of premium dairy and consumer food products in Indonesia, a market poised for significant growth driven by a rising middle class, increasing health consciousness, and urbanization. The company holds a dominant market share, particularly in the yogurt category.
  • Robust Financial Performance and Strong Growth Track Record: CMRY has demonstrated an exceptional growth trajectory, with a 3-year revenue CAGR of 30.13% and a net income CAGR of 24.35%. This is underpinned by successful product innovation and expansion of its distribution network, leading to consistent margin expansion and strong free cash flow generation.
  • Strategic Focus on Innovation and Distribution Expansion: The company’s strategy centers on continuous product innovation in both its dairy (Cimory brand) and consumer foods (Kanzler brand) segments, coupled with an aggressive expansion of its distribution channels, including modern trade, general trade, and its unique direct-to-consumer ‘Miss Cimory’ network. This dual focus is expected to sustain its growth momentum and market leadership.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Wayfair: What You Didn’t Know About Its Multichannel Fulfillment Takeover!- Major Drivers

By Baptista Research

  • Wayfair’s latest quarterly performance provides insight into both the company’s strategic achievements and the broader challenges it faces in a fluctuating market environment.
  • During Q3 2025, Wayfair experienced a notable 9% year-over-year revenue growth excluding its exit from Germany, marking acceleration despite a sluggish housing market.
  • This growth was accompanied by a significant surge in adjusted EBITDA, rising by over 70% year-over-year, with an adjusted EBITDA margin reaching 6.7%, the highest for Wayfair outside of the pandemic period.

Black Rock Coffee Bar (BRCB US): Limited but Direct US & Global Index Inclusion

By Dimitris Ioannidis

  • Black Rock Coffee Bar (BRCB US) went public on 12 September 2025 on Nasdaq and has a current market cap of $1.2bn.
  • Inclusion in US indices is expected in December 2025 and in Global index in February 2026, as the security meets eligibility criteria before lock-up expiry mainly due to ~100% float.
  • Exclusion from certain US and Global index is anticipated due to limited market cap.

Ferrari (RACE US) Q3 FY25: Beat + Revision Of Guidance Upwards

By Sameer Taneja

  • Ferrari N.V. (RACE US) reported Q3 FY25 revenue and earnings growth of 7% and 3% YoY, respectively (4% above analysts’ estimates), due to better mix and personalization.
  • Management is confident it will meet its conservative (revised upwards in capital markets day) FY25 guidance, projecting baseline revenue and EPS growth of 6% and 4% YoY, respectively.
  • The stock trades at 38.4x FY25 PE and 22.4x EV-EBITDA. Ferrari N.V. (RACE US)  continues to maintain its unique pricing power, driven by its loyal customer base.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: SK Square , Xylem Inc, Veralto , Ningbo Joyson Electronic, Hesai Group, Impro Precision Industries, Grab Holdings , Toa Corp, Yamada Consulting Group Co L, Car Inc and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Reading the Latest Flow Patterns to Time a SK Square NAV Squeeze Trade
  • Xylem Teams Up with Amazon: How Smart Water Tech Is Reshaping Global Cities!
  • Veralto’s Data Center Revolution – How Water Tech Became the Next Big Thing in AI!
  • Ningbo Joyson IPO Trading: Tight Premium and Mediocre Insti Demand
  • Primer: Hesai Group (2525 HK) – Nov 2025
  • Primer: Impro Precision Industries (1286 HK) – Nov 2025
  • Grab Holdings: Growth Engines Continue to Rev – What’s Powering the Momentum?
  • Toa Corp (1885 JP): Coverage Initiation
  • Yamada Consulting Group Co L (4792 JP): 1H FY03/26 flash update
  • Primer: Car Inc (699 HK) – Nov 2025


Reading the Latest Flow Patterns to Time a SK Square NAV Squeeze Trade

By Sanghyun Park

  • Retail flow drove the ratio: selling pushed it higher, buying dragged it lower. Pre‑Sept they dip‑bought and flipped; since late Sept they’ve chased longs, fueling Hynix’s rally.
  • Instos joined retail chasing Hynix, juicing momentum; KRX’s investment‑alert acts as a speed bump, likely cooling hot‑money flows and tilting the ratio in Square’s favor.
  • But retail still drives Hynix; until they cool off, Square NAV squeeze is early. A sector‑wide AI pivot cooling retail frenzy is the real catalyst, bigger than KRX’s alert.

Xylem Teams Up with Amazon: How Smart Water Tech Is Reshaping Global Cities!

By Baptista Research

  • Xylem Inc., a leading global water technology company, reported solid results in the third quarter of 2025.
  • The company demonstrated strong financial performance with notable growth across its segments and has adjusted its full-year outlook upwards due to ongoing robust demand and efficient execution of its strategic initiatives.
  • Positively, Xylem registered an increase in revenue across all its segments, with a marked double-digit growth in both Measurement and Control Solutions (MCS) and Water Solutions and Services (WSS).

Veralto’s Data Center Revolution – How Water Tech Became the Next Big Thing in AI!

By Baptista Research

  • Veralto Corporation delivered a robust yet nuanced performance in the third quarter of 2025, reflecting significant progress across its key business segments amidst a continually evolving macroeconomic landscape.
  • The company reported a 5.1% increase in core sales and an 11% growth in adjusted earnings per share, propelled by strong execution within its Water Quality and Product Quality & Integrity (PQI) sectors.
  • Despite navigating challenges such as global trade policy shifts, Veralto raised its full-year adjusted earnings per share guidance, showcasing resilience and adaptability.

Ningbo Joyson IPO Trading: Tight Premium and Mediocre Insti Demand

By Nicholas Tan

  • Ningbo Joyson Electronic (600699 CH) is looking to raise up to US$471m in its upcoming Hong Kong IPO.
  • NBJ, is an intelligent automotive technology solution provider, offering advanced products and solutions across the auto part industry’s key areas including automotive electronics and automotive safety.
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

Primer: Hesai Group (2525 HK) – Nov 2025

By αSK

  • Global LiDAR Market Leader Poised for Growth: Hesai Group is a global leader in the LiDAR (Light Detection and Ranging) solutions market, holding the top position in terms of revenue for three consecutive years. The company has a dominant market share in both the automotive and robotaxi segments, with a 37% global market share by revenue in 2023. Positioned to capitalize on the rapidly expanding LiDAR market, which is projected to grow at a CAGR of over 12-20% annually, Hesai is well-situated to benefit from the increasing adoption of Advanced Driver Assistance Systems (ADAS) and autonomous vehicles.
  • Strong Revenue Growth and Path to Profitability: The company has demonstrated impressive top-line growth, with revenues increasing significantly year-over-year. Recent quarterly results show a marked improvement in financial performance, with a substantial narrowing of net losses and the achievement of non-GAAP profitability ahead of schedule. This is driven by a massive increase in LiDAR shipments, particularly for ADAS applications, reflecting strong market demand and successful scaling of its in-house manufacturing capabilities.
  • Geopolitical Risks and Competitive Pressures Remain Key Overhangs: Despite its market leadership and growth trajectory, Hesai faces significant risks. The company was added to the U.S. Department of Defense’s list of “Chinese Military Companies,”which it vehemently disputes as baseless and commercially motivated. This designation, coupled with intense competition in the LiDAR space leading to pricing pressure, creates uncertainty and could impact its global expansion plans and margin stability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Impro Precision Industries (1286 HK) – Nov 2025

By αSK

  • Diversified End-Market Exposure Mitigates Cyclicality: Impro serves a wide range of industries, including automotive, high-horsepower engines, aerospace, medical, and construction. This diversification helps to cushion the impact of downturns in any single sector. Recent strength in the aerospace and high-horsepower engine (driven by AI data center demand) segments has offset weakness in others.
  • Strong Financial Performance and Shareholder Returns: The company has demonstrated a solid growth track record, particularly over the last three years, with an 18.95% CAGR in net income and a 40.46% CAGR in free cash flow. This financial strength supports a consistent and attractive dividend yield, which stood at 8.2% in the most recent fiscal year.
  • Strategic Global Footprint and ‘One-Stop Shop’ Capabilities: With manufacturing facilities in China, Mexico, Turkey, and Europe, Impro is well-positioned to serve its global customer base and mitigate geopolitical risks. Its comprehensive service offering, from design and casting to precision machining and surface treatment, provides a key competitive advantage and deepens customer relationships.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Grab Holdings: Growth Engines Continue to Rev – What’s Powering the Momentum?

By Devi Subhakesan

  • Grab Holdings (GRAB US)  delivered solid Q3 2025 results with healthy revenue and margin expansion across segments, but lagged consensus forecasts.
  • Growth in Q32025 was driven by rising MTU, strong Mart and Advertising momentum among other factors.
  • Management believes that the growth seen in recent quarters are sustainable, without sacrificing profitability. Raised full year guidance marginally.

Toa Corp (1885 JP): Coverage Initiation

By Shared Research

  • In FY03/25, the company reported record-high results, with revenue of JPY330.5bn (+16.4% YoY), operating profit of JPY20.6bn (+19.7% YoY), recurring profit of JPY20.1bn (+20.7% YoY), and net income attributable to owners of the parent of JPY14.9bn (+41.8% YoY).
  • Orders (parent) totaled JPY353.8bn (+0.3% YoY), also a record high. Revenue exceeded the initial forecast by 10.2%, reflecting steady progress on large projects in the Domestic Civil Engineering, Domestic Building Construction, and Overseas businesses.
  • Orders (parent) surpassed the initial forecast by 68.5%, boosted by early booking of overseas projects originally scheduled for FY03/26.

Yamada Consulting Group Co L (4792 JP): 1H FY03/26 flash update

By Shared Research

  • Revenue increased by 7.6% YoY to JPY13.4bn, while operating profit decreased by 27.9% YoY to JPY2.1bn.
  • Consulting business revenue was JPY9.6bn, with a 41.3% YoY decline in operating profit, driven by higher SG&A expenses.
  • Investment business revenue rose 64.2% YoY to JPY3.7bn, with operating profit exceeding the full-year target at 113.2%.

Primer: Car Inc (699 HK) – Nov 2025

By αSK

  • Privatization and Delisting: Car Inc. was privatized by private equity firm MBK Partners and delisted from the Hong Kong Stock Exchange on July 8, 2021, following a period of significant financial distress and corporate governance concerns. This report analyzes the company’s performance and position leading up to this event.
  • Market Leadership Under Pressure: Historically one of China’s largest car rental companies, Car Inc.’s market position was eroded by intense competition, the negative impact of the COVID-19 pandemic, and its association with the Luckin Coffee accounting scandal through its founder, Charles Lu Zhengyao.
  • Challenging Financial Trajectory: The company exhibited a significant deterioration in financial performance, with declining revenue, negative margins, and substantial net losses in the period leading up to its privatization. This was a stark reversal from its previously profitable operations.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Lendlease Global Commercial REIT, Commonwealth Bank of Australia, European Residential Real Esta, Sti Education Systems, Financiere De Tubize SA, NCR Atleos , Exzeo Group, Big Yellow, New World Development, Qudian Inc and more

By | Daily Briefs, Financials

In today’s briefing:

  • Lendlease REIT Placement: DPU Accretive, past Offering Did Well
  • Australia’s Big Banks: Options Flash Mixed Signals Ahead of Earnings
  • European Residential Reit (ERE.UN) – Thursday, Aug 7, 2025
  • Primer: Sti Education Systems (STI PM) – Nov 2025
  • Primer: Financiere De Tubize SA (TUB BB) – Nov 2025
  • NCR Atleos – Growth at a Value Price
  • Exzeo Group Inc. (XZO): IPO Opens Flat for the HCI Spin-Off Insurtech
  • Primer: Big Yellow (BYG LN) – Nov 2025
  • New World Development – Event Flash – Exchange Offers For All USD Perps And Bonds – Lucror Analytics
  • Primer: Qudian Inc (QD US) – Nov 2025


Lendlease REIT Placement: DPU Accretive, past Offering Did Well

By Nicholas Tan

  • Lendlease Global Commercial REIT (LREIT SP)  is looking to raise at least S$270m in a private placement, to fund acquisition of 70% interest in PLQ Mall.
  • Overall, this deal represents 44.2 days of ADV and 16.5% of shares outstanding.
  • In this note, we comment on the deal dynamics and run the deal through our ECM framework.

Australia’s Big Banks: Options Flash Mixed Signals Ahead of Earnings

By Gaudenz Schneider

  • Australia’s largest banks are due to report within the next four trading days. Collectively, they account for 23% of the S&P/ASX 200 (AS51 INDEX).
  • A beat or miss of expectations can result in a strong move, up or down. This Insight analyzes options to provide an indication of how big a move to expect.
  • Option traders price in outsized moves for several but not all banks, with ANZ (ANZ AU) as the largest outlier.

European Residential Reit (ERE.UN) – Thursday, Aug 7, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • European Residential REIT is nearing the end of its public tenure, focusing on Dutch apartment buildings and controlled by Canadian Apartment Properties REIT.
  • The REIT is expected to provide strong risk-adjusted returns as it approaches liquidation, with recent activities indicating this trajectory.
  • In May 2024, ERE announced plans to boost capital generation, and by July 2024, it completed asset sales of EUR 116 million, achieving prices at or above IFRS values.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Primer: Sti Education Systems (STI PM) – Nov 2025

By αSK

  • Record Enrollment Driving Financial Growth: STI is experiencing a strong growth trajectory, driven by a 15% increase in student enrollment to a record high of 138,060 for the 2024-2025 school year. This surge, particularly in higher-margin university programs regulated by CHED, has significantly boosted revenues and profitability, with net income climbing 38% in the most recent fiscal year.
  • Favorable Industry Dynamics: The Philippine education market is valued at over USD 31 billion and is projected to grow significantly, supported by a large youth population and government initiatives to improve educational access and quality. STI, as the largest network of private schools in the country, is well-positioned to capitalize on this expanding market.
  • Attractive Valuation with Operational Efficiency Focus: The company trades at a P/E ratio that is favorable compared to the Asian Consumer Services industry average. Management’s focus on improving operational efficiency and cost management has led to expanding margins for three consecutive years, enhancing shareholder value.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Financiere De Tubize SA (TUB BB) – Nov 2025

By αSK

  • Pure-Play Holding Company: Financiere De Tubize SA is a Belgian holding company whose sole significant asset is a 36.27% stake in the global biopharmaceutical company UCB SA. Its valuation and performance are directly linked to UCB’s success.
  • Vehicle for UCB Exposure at a Discount: The primary investment thesis for Tubize is gaining exposure to UCB at a persistent, albeit fluctuating, discount to its Net Asset Value (NAV). This discount reflects its status as a holding company.
  • Long-Term Family Control: Tubize’s mission is to act as a stable, long-term reference shareholder for UCB, representing the interests of the founding Janssen family and like-minded investors. This structure provides UCB with the stability needed for long-term R&D and strategic investments.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


NCR Atleos – Growth at a Value Price

By Richard Howe

  • NCR Atleos (NATL) is a 2023 spin-off that is focused on the ATM market.
  • It is benefiting from banks outsourcing their ATM operations which is driving high margin growth (ATMaaS revenue up 32% and backlog up 105% in the last quarter).
  • The company is going to grow earnings at a 20% rate for the foreseeable future. 

Exzeo Group Inc. (XZO): IPO Opens Flat for the HCI Spin-Off Insurtech

By IPO Boutique

  • Exzeo priced mid-range at $21.00 and traded flat, signaling a disciplined and stable market entrance.
  • Profitable, zero-debt insurtech spin-off from HCI boasting 50%+ EBITDA margins and $195M ARR.
  • Expanding beyond 13 states into major markets; poised for sustainable, high-margin growth under proven leadership.

Primer: Big Yellow (BYG LN) – Nov 2025

By αSK

  • Big Yellow is the UK’s leading self-storage brand, demonstrating strong brand recognition and a dominant market position, particularly in London and the South East.
  • The company operates as a Real Estate Investment Trust (REIT), focusing on a portfolio of high-quality, purpose-built, and predominantly freehold properties in prime, visible locations, which supports high margins and asset values.
  • Future growth is underpinned by a solid development pipeline aimed at expanding lettable space to meet growing demand, coupled with a commitment to returning value to shareholders through a consistent dividend policy.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


New World Development – Event Flash – Exchange Offers For All USD Perps And Bonds – Lucror Analytics

By Leonard Law, CFA

  • We believe that New World Development’s (NWD) focus for the proposed exchange offers is to reduce its outstanding debt, mainly by restructuring the existing perps.
  • Hence, the exercise, if completed, would be credit positive for the company.
  • This would in turn support the prices of the existing straight bonds.

Primer: Qudian Inc (QD US) – Nov 2025

By αSK

  • Qudian is in a state of profound strategic transition, having pivoted away from its original online micro-lending business and subsequently winding down newer ventures like ‘QD Food’ and its ‘Fast Horse’ last-mile delivery service due to intense competition.
  • The company’s financial profile is characterized by a dramatic decline in operational revenue, offset by significant interest and investment income, which has recently returned the company to profitability. This unusual composition is a direct result of its strategic shifts and monetization of its large cash reserves.
  • Trading at a significant discount to its book value, the company’s primary value proposition is its substantial cash and cash equivalents. An aggressive share repurchase program is in place to return value to shareholders, but the future operational direction remains highly uncertain, posing significant execution and regulatory risks.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Mr. DIY Holding (Thailand) and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Mr DIY Thailand IPO Trading: Shareholders Pledged Lockup; Midteens Upside


Mr DIY Thailand IPO Trading: Shareholders Pledged Lockup; Midteens Upside

By Nicholas Tan

  • Mr. DIY Holding (Thailand) (2472516D TB) is looking to raise up to US$173m in its upcoming Thai IPO.
  • It is recognized as the largest and fastest growing home improvement and general lifestyle retailer in Thailand.
  • In this note we will talk about the trading dynamics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: SK Hynix, D’Alba Global, POSCO Holdings, Orion Corp, Hana Financial, Welcron Kangwon, E&D Co Ltd, Shinpoong Pharmaceutical, SK Bioscience , Top Material and more

By | Daily Briefs, South Korea

In today’s briefing:

  • SK Hynix Should Continue to Benefit from Local Flow.
  • D’Alba Global – End of Lockup Period For 10% of Outstanding Shares
  • POSCO Holdings — From Steel Giant to Green Materials Powerhouse
  • Primer: Orion Corp (271560 KS) – Nov 2025
  • Korean Banks; Stick with Hana (086790 KS) On the Buy List
  • Primer: Welcron Kangwon (114190 KS) – Nov 2025
  • Primer: E&D Co Ltd (101360 KS) – Nov 2025
  • Primer: Shinpoong Pharmaceutical (019170 KS) – Nov 2025
  • SK Bioscience (302440 KS): IDT Drives Strong 3Q Performance; Operating Loss Narrows
  • Primer: Top Material (360070 KS) – Nov 2025


SK Hynix Should Continue to Benefit from Local Flow.

By Ken S. Kim


D’Alba Global – End of Lockup Period For 10% of Outstanding Shares

By Douglas Kim

  • There is an end of a lock-up period for 1.3 million shares (10% of outstanding shares) for d’Alba Global starting 22 November 2025.
  • This could potentially result in additional selling by insiders which could negatively impact its share price in the coming weeks. We remain Bearish on d’Alba Global.
  • The overall proportion of freely tradable shares, which was only 32.7% right after listing, will increase to 83.9% one year later. 

POSCO Holdings — From Steel Giant to Green Materials Powerhouse

By Rahul Jain

  • POSCO is shifting from cyclical steel to sustainable, high-margin materials and hydrogen technologies.
  • Earnings recovery and RBM scale-up underpin a 15–35% re-rating potential by FY27.
  • Strong asset base, improving margins, and carbon-neutral roadmap limit downside risk.

Primer: Orion Corp (271560 KS) – Nov 2025

By αSK

  • Dominant Market Position in High-Growth Emerging Markets: Orion holds a commanding presence in the confectionery markets of Vietnam and Russia, driven by the exceptional brand equity of its flagship product, Choco Pie. Continued capacity expansion in these regions is poised to capture further growth.
  • Strong Financial Performance and Shareholder Returns: The company has demonstrated a robust track record of revenue and net income growth, coupled with a significant increase in dividend payouts. This highlights efficient operations and a commitment to returning value to shareholders.
  • Diversification and Future Growth Engines: Strategic initiatives to expand into new business areas, including beverages, convenient meal replacements, and biotech, present long-term growth opportunities beyond the core confectionery segment, mitigating reliance on a single product category.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Korean Banks; Stick with Hana (086790 KS) On the Buy List

By Victor Galliano

  • Hana Financial remains our buy pick among Korean banks; it is close to the top our scorecard, it remains attractively valued and its returns are improving
  • Hana is trading at a large PBV discount to KB Financial; this currently stands at a 30%+ discount which is over one standard deviation from the historical PBV discount mean
  • Furthermore, we see that this relatively dovish phase of monetary policy, Hana appears to have more limited downside risk than its peers in terms of further interest spread erosion

Primer: Welcron Kangwon (114190 KS) – Nov 2025

By αSK

  • Welcron Kangwon is undergoing a significant transformation, leveraging its legacy in the industrial boiler market to penetrate the high-growth secondary battery equipment sector. This strategic pivot has driven remarkable revenue growth, though profitability and cash flow remain volatile.
  • The company is well-positioned to benefit from powerful secular tailwinds, including global industrialization, increasing demand for energy efficiency, and stricter environmental regulations. Its core products, such as waste heat recovery systems, directly address these trends.
  • Despite strong top-line momentum, significant risks persist. Financial performance is characterized by fluctuating profitability and deeply negative free cash flow, raising concerns about earnings quality and financial stability. The business model’s reliance on large, project-based contracts contributes to this inherent volatility.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: E&D Co Ltd (101360 KS) – Nov 2025

By αSK

  • E&D Co Ltd is a high-growth, high-risk player in the burgeoning secondary battery and environmental catalyst markets. Its core value proposition lies in its proprietary technologies for producing precursors for electric vehicle (EV) batteries and catalysts for emission control.
  • The company exhibits a stellar long-term revenue and net income growth trajectory, driven by strong secular tailwinds in its end markets. However, this growth has been accompanied by extreme volatility in profitability and, most critically, a consistent and severe burn of operating and free cash flow.
  • An investment in E&D is a bet on the successful scaling of its operations to meet surging demand and an eventual transition to sustainable positive cash flow. The high uncertainty is balanced by the significant upside potential if the company can overcome its operational and financial challenges.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Shinpoong Pharmaceutical (019170 KS) – Nov 2025

By αSK

  • Shinpoong Pharmaceutical is a South Korean pharmaceutical company transitioning from a generics manufacturer to an R&D-focused entity, highlighted by its antimalarial drug Pyramax and a pipeline focused on cardiovascular and neurological diseases.
  • The company has experienced significant financial headwinds, with consistent net losses and negative cash flow over the past three fiscal years, although recent quarterly results in 2025 show a marked improvement towards profitability.
  • Future growth hinges on the successful clinical progression and commercialization of its key pipeline asset, Otaplimastat (SP-8203) for acute ischemic stroke, and its ability to expand its global market presence for existing products.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


SK Bioscience (302440 KS): IDT Drives Strong 3Q Performance; Operating Loss Narrows

By Tina Banerjee

  • SK Bioscience (302440 KS) reports 2.5x jump in revenue and narrowing operating loss in 3Q25, driven by additional revenue contribution and improving profitability of German subsidiary, IDT Biologika.
  • For 2025, SKBS guided for IDT revenue of KRW410B. With 3Q25 YTD revenue reaching KRW341B (up 19% YoY), IDT is expected to beat the guidance.
  • 2026 will be crucial for the company, with couple of vaccine candidates entering late-stage trials. PCV21 global Phase 3 trial is ongoing. This should keep R&D spend elevated.

Primer: Top Material (360070 KS) – Nov 2025

By αSK

  • Top Material is a South Korean company operating in the high-growth secondary battery materials sector, specifically focusing on the production of cathode active materials (CAMs), a critical component for lithium-ion batteries.
  • The company is navigating a volatile market characterized by the rapid expansion of the electric vehicle (EV) and energy storage systems (ESS) industries, which are the primary demand drivers. However, this growth is tempered by intense competition, raw material price fluctuations, and evolving battery chemistries.
  • Financial performance has been erratic, with strong growth in 2022 and 2023 followed by a significant downturn in 2024, reflecting industry-wide challenges. The company’s future hinges on its ability to manage costs, secure stable raw material supplies, and align its product development with the dominant battery technologies.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars